Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 317 Gastrointestinal Stromal Tumors 108 Neoplasms 105 Breast Neoplasms 92 Melanoma 81 Ovarian Neoplasms 79 Neoplasm Metastasis 74 Carcinoma, Non-Small-Cell Lung 74 Colorectal Neoplasms 70 Osteosarcoma 61 Stomach Neoplasms 59 Pancreatic Neoplasms 55 Bone Neoplasms 55 Prostatic Neoplasms 51 Head and Neck Neoplasms 48 Glioblastoma 48 Sarcoma, Ewing 47 Lung Neoplasms 45 Esophageal Neoplasms 42 Squamous Cell Carcinoma of Head and Neck 41 Carcinoma, Renal Cell 40 Uterine Cervical Neoplasms 39 Sarcoma, Kaposi 38 Lymphoma 37 Urinary Bladder Neoplasms 36 Sarcoma, Synovial 36 Recurrence 35 Dendritic Cell Sarcoma, Interdigitating 34 Lymphoma, Non-Hodgkin 33 Endometrial Neoplasms 33

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pain, Intractable × Sarcoma × Clear all

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡